Oncology Pharma Inc.
ONPH
$0.0001
$0.000.00%
OTC PK
| 12/31/2004 | 09/30/2004 | 06/30/2004 | 03/31/2004 | 12/31/2003 | |
|---|---|---|---|---|---|
| Net Income | -507.00K | -954.00K | -1.37M | -1.57M | -1.52M |
| Total Depreciation and Amortization | 12.00K | 33.00K | 54.00K | 81.00K | 157.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -78.00K | -78.00K | -75.00K | -135.00K | 125.00K |
| Change in Net Operating Assets | -195.00K | -146.00K | -425.00K | -381.00K | -166.00K |
| Cash from Operations | -768.00K | -1.15M | -1.82M | -2.00M | -1.40M |
| Capital Expenditure | 0.00 | 0.00 | -17.00K | -17.00K | -17.00K |
| Sale of Property, Plant, and Equipment | 133.00K | 133.00K | 133.00K | 133.00K | 2.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 133.00K | 133.00K | 116.00K | 116.00K | -15.00K |
| Total Debt Issued | 290.00K | 168.00K | 168.00K | 85.00K | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 0.00 | 0.00 | 466.00K | 466.00K | 467.00K |
| Repurchase of Common Stock | -- | -5.00K | -5.00K | -5.00K | -5.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 290.00K | 163.00K | 629.00K | 546.00K | 462.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -345.00K | -849.00K | -1.07M | -1.34M | -953.00K |